Zuraxim 250 Tablet contains Cefuroxime 250 mg, a second-generation cephalosporin antibiotic effective against a broad spectrum of bacterial infections. It acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. Zuraxim 250 is indicated for the treatment of respiratory tract infections, including acute bacterial sinusitis, bronchitis, and pneumonia, as well as urinary tract infections, skin and soft tissue infections, and uncomplicated gonorrhea. This antibiotic is effective against both Gram-positive and Gram-negative organisms, including Streptococcus pneumoniae, Haemophilus influenzae, Escherichia coli, and Klebsiella species. The medication is administered orally, with absorption enhanced when taken with food. Dosage and duration of therapy should be determined based on the severity of infection and patient-specific factors such as renal function. Common adverse effects include gastrointestinal disturbances such as diarrhea, nausea, and abdominal discomfort, as well as hypersensitivity reactions in patients with a history of penicillin or cephalosporin allergy. Caution is advised in patients with renal impairment, and dosage adjustment may be necessary. Zuraxim 250 should be used under medical supervision to ensure appropriate use and to minimize the development of antibiotic resistance.